NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) | PAR 25 166

Frequently Asked Questions (FAQs)

1) What is the name and identifier of this funding opportunity?

The opportunity is titled NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed). The funding opportunity number is PAR 25-166.

2) Who is the issuing agency?

The issuing agency is the National Institutes of Health (NIH), with the opportunity associated with NIDCR priorities in dental, oral, and craniofacial research.

3) What type of grant mechanism is this?

This is an NIH R03 small research grant mechanism intended for small, focused, tightly scoped projects that can produce clear, publishable outcomes, feasibility evidence, or targeted discoveries.

4) What is the central goal of this program?

The central goal is to support research that generates new biological or clinical insight in human dental, oral, or craniofacial (DOC) biology and DOC-related diseases and conditions by conducting rigorous computational and statistical analyses of existing, publicly available genomics datasets.

5) What is the main emphasis: new data collection or analysis of existing data?

The main emphasis is on analysis of existing, publicly available genomics data, not on collecting large new datasets. The program is designed around reanalysis, integration, and interpretation of existing resources to answer important DOC-relevant questions.

6) Are clinical trials allowed?

No. This opportunity is explicitly Clinical Trial Not Allowed. Projects should not include the prospective assignment of human participants to interventions to evaluate health-related outcomes.

7) Does the project have to be only genomics, or can it include other data types?

Projects may combine genomics with complementary data types when helpful, such as phenotypes, clinical variables, imaging-derived measures, environmental or social determinants data, microbiome profiles, or other omics layers, as long as the core contribution is grounded in rigorous analysis of existing genomics resources.

8) What kinds of analytic approaches are encouraged?

The announcement strongly encourages modern analytic approaches and thoughtful integration of data, including:

• Established computational pipelines
• New methods developed within the project (when justified by the scientific question)
• Data and metadata mining
• Harmonization across studies
• Multi-dataset integration
• Advanced AI/ML/DL strategies (when appropriate and interpretable)

9) Is AI/ML/DL required?

No. AI/ML/DL approaches are encouraged when they are justified by the scientific question and are likely to produce interpretable, reliable results from the available data. The intent is not to use AI for its own sake.

10) Can applicants propose developing new computational or analytic methods?

Yes. Proposals that build or improve analytic methods are allowed, but they are expected to be tied to a meaningful DOC research question and to explain why the method is needed and how it advances the field.

11) Is validation required even though the work focuses on existing data?

Yes. Each project is expected to include validation beyond the initial computational discovery step. Validation can be:

• Experimental (for example, targeted wet-lab confirmation in an appropriate model system), or
• In silico (for example, replication in independent datasets, sensitivity analyses, orthogonal computational confirmation, or benchmarking against known truth sets).

12) What validation expectations apply if a new analytic method is developed?

If the project includes development of a new analytic approach, validation is required to show the method works as intended, performs better than alternatives, or is otherwise fit for the proposed purpose.

13) What scientific areas does NIDCR emphasize within DOC genomics?

NIDCR highlights priorities within DOC genomics, including:

• Studies that improve understanding of human biological pathways relevant to oral and craniofacial health
• Work that could help identify intervention targets or improve interpretation of known genetic variants
• Research that helps define or refine the pathogenicity of variants already implicated in disease

14) Are oral health disparities specifically prioritized?

Yes. Projects aimed at understanding oral health disparities are explicitly prioritized, especially when the findings can inform strategies to improve oral health outcomes for all individuals.

15) What kinds of disparities-focused questions fit this opportunity?

Examples of disparities-related themes encouraged by the announcement include investigating how genetic architecture, ancestry, social and environmental exposures, access to care, or structural factors interact to influence oral health, provided the work remains grounded in appropriate datasets and rigorous analyses.

16) What is the activity category and CFDA number?

The activity category is Health, and the CFDA number is 93.121.

17) Who is eligible to apply?

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants listed include:

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and state-controlled institutions of higher education
• Private institutions of higher education
• Federally recognized Native American tribal governments
• Native American tribal organizations (other than federally recognized tribal governments)
• Public housing authorities / Indian housing authorities
• Nonprofits with or without 501(c)(3) status (other than institutions of higher education)
• For-profit organizations (other than small businesses)
• Small businesses
• Other entities

18) Are institutions serving underrepresented populations explicitly included?

Yes. The NOFO explicitly calls out additional eligible applicant categories such as:

• Historically Black Colleges and Universities (HBCUs)
• Hispanic-serving Institutions
• Tribally Controlled Colleges and Universities (TCCUs)
• Alaska Native and Native Hawaiian Serving Institutions
• Asian American Native American Pacific Islander Serving Institutions (AANAPISI)
• Faith-based or community-based organizations

19) Are federal agencies, regional organizations, U.S. territories, and foreign organizations eligible?

Yes. The NOFO also includes eligible categories such as eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations).

20) What is the original closing date listed for this opportunity?

The opportunity record lists an original closing date of 2026-05-07.

21) What is the creation date listed for this opportunity record?

The opportunity record shows a creation date of 2024-11-18.

22) Does the listing provide an award ceiling or the expected number of awards?

No. The provided listing does not specify an award ceiling or the expected number of awards.

23) What project style is this program trying to support?

The structure signals support for modestly sized, high-impact projects that leverage existing genomics resources, produce validated results, and, when appropriate, contribute reusable tools or analytic frameworks for other researchers.

24) What topic areas are in-scope?

In-scope topics include research questions in human dental, oral, or craniofacial (DOC) biology and DOC-related diseases and conditions that can be addressed through analysis of existing genomics datasets and appropriate validation.

25) What would be out of scope based on the information provided?

Out of scope based on the information provided would be projects centered on conducting a clinical trial (prospective assignment to an intervention to assess health outcomes) or projects whose main contribution is collecting large new datasets rather than analyzing existing publicly available genomics resources.